LabCompass

Wade Clapp

Medicine · Indiana University

OpenAlex
Neurofibromatosis and Schwannoma CasesDNA Repair MechanismsNeuroblastoma Research and TreatmentsGlioma Diagnosis and TreatmentMeningioma and schwannoma management

Publications

66

Citations

1,163

Est. group size

—

Recurring co-author estimate

Active years

22

Publishing since 2004

Research summary
AI-generated

Wade Clapp conducts medical research on neurofibromatosis, a group of genetic conditions that cause tumors to grow on nerves, including neurofibromatosis type 1, type 2, and schwannomatosis. Much of the work involves clinical trials testing drugs (such as MEK inhibitors and bevacizumab) to treat tumors like plexiform neurofibromas and vestibular schwannomas in children and adults. The research is often carried out through multicenter collaborative trial networks.

Neurofibromatosis type 1 and type 2Plexiform neurofibromas and schwannomasClinical trials of targeted cancer therapiesMEK inhibitors and anti-tumor drugsPediatric tumor treatment

Publication activity has been irregular over the last decade, with several years showing no listed publications and a modest recent average of about 1.6 per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
2017: 3 publications172018: 2 publications18192020: 4 publications20212022: 1 publication22232024: 5 publications5242025: 2 publications2526
Recent publications
Publishes in
  • Neuro-Oncology×8
  • Neurology×5
  • Journal of Clinical Oncology×2
  • bioRxiv (Cold Spring Harbor Laboratory)×2
  • Neuro-Oncology Pediatrics×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile